Trial Profile
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 13 Mar 2012 New trial record